Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats-Reference-Cited by-同舟云学术

Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats

Published:2012-04-17 Issue:4 Volume:17 Page:380-389
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:

Author:

YU WEI-MIN,WANG HUAN,REN XIAO-JUN,LIU JUN-PING,WANG JIAN-YING

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1797.2012.01563.x/fullpdf

Reference30 articles.

1. Diabetic nephropathy: Diagnosis, prevention, and treatment;Gross;Diabetes Care,2005

2. Review: The problem of diabetic nephropathy and practical prevention of its progression;Wright;Br. J. Diabetes Vasc. Dis.,2008

3. From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines;Schrijvers;Endocrine,2004

4. The role of inflammatory cytokines in diabetic nephropathy;Navarro-González;J. Am. Soc. Nephrol.,2008

5. Inflammation and diabetic nephropathy;Mora;Curr. Diab. Rep.,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antirheumatic drug leflunomide attenuates atherosclerosis by regulating lipid metabolism and endothelial dysfunction via DHODH/AMPK signaling pathway;International Journal of Biological Sciences;2024

2. Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy;Frontiers in Endocrinology;2022-08-30

3. Experimental study on renoprotective effect of intermedin on diabetic nephropathy;Molecular and Cellular Endocrinology;2021-05

4. Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6;Renal Failure;2019-01-01

5. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy;Oncotarget;2017-03-22